SCHEMBL9889142

SCHEMBL9889142

C=CCc1cc(CO[Si](C(C)C)(C(C)C)C(C)C)ccc1O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 11/20 0.47
GABRB2 P47870 11/20 0.47
CNR2 P34972 4/20 0.46
ALOX5 P09917 3/20 0.46
CNR1 P21554 3/20 0.46
POLB P06746 2/20 0.46
MEN1 O00255 2/20 0.46
GAA P10253 2/20 0.46
MAPT P10636 2/20 0.46
KMT2A Q03164 2/20 0.46
GABRB1 P18505 1/20 0.46
RXRA P19793 1/20 0.46
GABRA5 P31644 1/20 0.46
GABRA3 P34903 1/20 0.46
GABRA2 P47869 1/20 0.46
ACE2 Q9BYF1 1/20 0.46
SIRT3 Q9NTG7 1/20 0.46
ALDH1A1 P00352 2/20 0.42
CYP3A4 P08684 1/20 0.42
AR P10275 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9052031 0.80 GABRA1 (0.46) GABRA1GABRB2CNR2ALOX5CNR1
SCHEMBL9889146 0.77 CCR5 (0.41) GABRA1GABRB2CNR2MEN1GAA
SCHEMBL821126 0.75 GABRA1 (0.72) GABRA1GABRB2CNR2ALOX5CNR1
SCHEMBL5882568 0.74 GABRA1 (0.61) GABRA1GABRB2CNR2ALOX5CNR1
SCHEMBL9436388 0.74 GABRA1 (0.61) GABRA1GABRB2CNR2ALOX5CNR1
SCHEMBL240238 0.73 GABRA1 (0.66) GABRA1GABRB2CNR2ALOX5CNR1
SCHEMBL29463215 0.73 GABRA1 (0.66) GABRA1GABRB2CNR2ALOX5CNR1
SCHEMBL20840187 0.73 GABRA1 (0.66) GABRA1GABRB2CNR2ALOX5CNR1
SCHEMBL8419816 0.73 GABRA1 (0.49) GABRA1GABRB2CNR2ALOX5CNR1
SCHEMBL8417679 0.73 GABRA1 (0.46) GABRA1GABRB2CNR2ALOX5CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150369816-A1 Polypeptide Immobilization UNIV CHICAGO (US) 2015-12-24 US disclosed
US-9074300-B2 Polypeptide immobilization THE UNIVERSITY OF CHICAGO (US) 2015-07-07 US disclosed
US-20120142547-A1 POLYPEPTIDE IMMOBILIZATION THE UNIVERSITY OF CHICAGO 2012-06-07 US disclosed
US-7888055-B2 Selectively binds with absolute control over orientation and density without requiring prior synthetic modification or purification to make a stable protein chip; rapid and irreversible; assaying kinase or protease activity THE UNIVERSITY OF CHICAGO (US) 2011-02-15 US disclosed
US-20080064606-A1 Polypeptide immobilization THE UNIVERSITY OF CHICAGO 2008-03-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080064606-A1 Polypeptide immobilization QPCTL, SURF4, QPCT GABRA1 1489/4885GABRB2 1666/4885CNR2 4750/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.